STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR (NASDAQ: VICR) insider sells repeated 20,000-share blocks under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Company: VICR insider disposition disclosed via Form 144. The filing lists multiple planned or completed sales executed under a Rule 10b5-1 plan by Patrizio Vinciarelli and institutional holders. Transactions include repeated blocks of 20,000 share sales in June 2026 and larger sales in March–April 2026.

The excerpt itemizes per-trade share counts and gross proceeds (e.g., $5,590,036.00 for a 20,000-share sale on 06/10/2026). The filing reports similar 10b5-1 dispositions across multiple dates; timing, aggregate totals, and remaining holdings are shown only as individual trade rows in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Repeated 10b5-1 sales by an insider are documented; filings are routine disclosures of dispositions.

The excerpt lists multiple sales executed under a Rule 10b5-1 plan by Patrizio Vinciarelli, with many 20,000-share transactions in June 2026 and larger blocks in March–April 2026. Each row pairs a trade date with a share count and gross proceeds.

These disclosures show transaction-level activity; whether the pattern materially alters ownership or company overhang depends on aggregate totals and outstanding share counts, which are not aggregated in the excerpt. Subsequent filings or detailed ownership tables would provide full post-transaction positions.

Single trade share count 20,000 shares multiple 20,000-share sales (e.g., <date>06/10/2026</date>)
Gross proceeds example $5,590,036.00 20,000-share sale on <date>06/10/2026</date>
Large block sale 50,000 shares sales on multiple March–April 2026 dates
Proceeds example for 50,000-share trade $9,809,142.46 50,000-share sale on <date>03/18/2026</date>
Institutional seller example 3,500 shares Brigham and Women's Hospital sale on <date>05/14/2026</date>
Proceeds example for institutional sale $1,043,623.00 Brigham and Women's Hospital 3,500-share sale on <date>05/14/2026</date>
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 11/10/1981 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the VICR Form 144 disclose about insider sales?

It discloses multiple sales executed under Rule 10b5-1 by Patrizio Vinciarelli and institutions. The excerpt lists individual trade dates, share counts (e.g., 20,000 shares) and gross proceeds for each transaction.

How large were typical trades listed in the VICR excerpt?

Many listed trades are blocks of 20,000 shares executed in June 2026. The excerpt also shows larger blocks in March–April 2026, including 50,000-share sales and other varying sizes listed with their gross proceeds.

Are the proceeds shown for each trade in the filing?

Yes. Each trade row pairs a share count with gross proceeds, for example $5,590,036.00 for a 20,000-share sale on 06/10/2026 and $9,809,142.46 for a 50,000-share sale on 03/18/2026.

Does the excerpt state whether sales were pre‑planned under a trading plan?

The excerpt labels many entries as "10b5-1 Sales," indicating the trades were effected under Rule 10b5-1 plans. The filing rows use that descriptor alongside dates, share counts, and gross proceeds for each sale.

Which other entities are named as sellers in the VICR excerpt?

The excerpt also lists institutional or charitable sellers by name and address, including Brigham and Women's Hospital and Lahey Hospital & Medical Center, with individual share counts and proceeds shown for their transactions.